BioSpace News Archive

Business

Zentek Signs Distribution Agreement with Southmedic Inc.

Zentek Ltd. has signed a Distribution Agreement with Southmedic Inc. for the distribution of Zentek’s patented ZenGUARD surgical masks.

January 19, 2023
·
3 min read
Business

Seagen to Host Conference Call and Webcast Discussion of Fourth Quarter and Full Year 2022 Financial Results on February 15, 2023

Seagen Inc. (Nasdaq: SGEN) today announced that it will report its fourth quarter and full year 2022 financial results on Wednesday, February 15, 2023 after the close of U.S. financial markets.

January 19, 2023
·
1 min read
Biotech Bay

SetPoint Medical Announces Expanded $65M Credit Facility to Support Development of the Company’s Novel Platform for Rheumatoid Arthritis

SetPoint Medical today announced a senior secured term loan facility of up to $65 million from Runway Growth Capital LLC (“Runway”), a leading provider of growth loans to both venture and non-venture backed companies.

January 19, 2023
·
3 min read
Business

Immunovia announces updated financial calendar for financial year 2023

Immunovia, a diagnostic company with the vision to revolutionize blood-based diagnostics and survival rates for patients with cancer, announces its financial calendar for 2023 and 2024.

January 19, 2023
·
1 min read
Business

Neuronetics and Greenbrook TMS Announce Six Year Exclusive Partnership

Neuronetics, Inc. (NASDAQ: STIM) and Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH), a leading provider of transcranial magnetic stimulation (“TMS”) therapy (“Greenbrook”), today announced an expanded commercial partnership through year end 2028.

January 19, 2023
·
5 min read
SELLAS Life Sciences to Host Key Opinion Leader Webinar on Galinpepimut-S Acute Myeloid Leukemia Program

SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”) will host a virtual key opinion leader event to discuss the current treatment landscape for patients suffering from acute myeloid leukemia (AML) and the potential for galinpepimut-S (GPS) as a treatment solution.

January 19, 2023
·
4 min read
Drug Development

ABVC BioPharma ABV-1505 ADHD Phase IIa Results Presented at 2023 APSARD Conference

ABVC BioPharma, Inc. today announced that Dr. Keith McBurnett, Professor of Psychiatry at the University of California San Francisco, presented the results of the Phase IIa study of its medical treatment, ABV-1505 ADHD, on January 14, 2023 at the 2023 Conference of The American Professional Society.

January 19, 2023
·
4 min read
Pharm Country

BioSig Issues Shareholder Update to Highlight Recent Achievements and Ongoing Developments

To date, the Company’s FDA 510(k)-cleared PURE EP™ System has been used in approximately 3,000 patient cases across the United States.

January 19, 2023
·
8 min read
Genetown

Celsius Therapeutics to Present Preclinical Data on Anti-TREM1 Antibody for Inflammatory Bowel Disease at 2023 Crohn’s & Colitis Congress

Celsius Therapeutics today announced that new data on CEL383, a potential first-in-class anti-TREM1 antibody for the treatment of inflammatory bowel disease (IBD), has been selected for oral presentation at the 6th Annual Crohn’s & Colitis Congress, taking place January 19-21, 2023, in Denver, Colorado.

January 19, 2023
·
2 min read
BioForest

The Robert A. Winn Diversity in Clinical Trials Award Program Established by the Bristol Myers Squibb Foundation to Expand with Amgen’s Commitment of $8 Million

The Robert A. Winn Diversity in Clinical Trials Award Program established by the Bristol Myers Squibb Foundation announced that Amgen, a global biotechnology company, has committed to contribute $8 million over the next four years.

January 19, 2023
·
7 min read